Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aurobindo Pharma USA is recalling 1,440 bottles of Clozapine 100mg tablets because a consumer reported finding 50mg tablets in the 100mg bottles.
A.P. Deauville, LLC is recalling Soft Whisper Dandruff Shampoo because it was produced with water that failed USP specifications.
QuVa Pharma is recalling 17,050 syringes of R.E.C.K. solution because they may contain particulate matter. The product was distributed nationwide in the US.
Alembic Pharmaceuticals is recalling aripiprazole tablets because bottles labeled as 2 mg contained 5 mg tablets. The error affects 19,153 bottles distributed nationwide.
Crown Laboratories is recalling Nystatin Cream, USP, because the product failed potency testing at the 9-month interval.
Crown Laboratories is recalling 62,274 tubes of Nystatin Cream because the product failed potency testing at the 9-month interval.
American Health Packaging is recalling 265 cartons of Nabumetone Tablets because the carton label did not include the required statement to dispense with the accompanying Medication Guide.
Pfizer is recalling Duavee tablets because they failed to meet dissolution specifications. The recall covers 544,400 packages distributed nationwide.
Rising Pharmaceuticals is recalling Timolol Maleate Sterile Ophthalmic Solution due to a carton label mix-up where 0.25% bottles were shipped in 0.5% cartons.
Rising Pharmaceuticals is recalling 15,072 bottles of Timolol Maleate 0.25% ophthalmic solution because some outer cartons were mislabeled as 0.5% strength.
AvKARE Inc. is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
PD-Rx Pharmaceuticals is recalling specific lots of metformin HCL ER 500 mg tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Apotex Inc. is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels.
SCA Pharmaceuticals is recalling 333 bags of Heparin Sodium 5,000 units due to out-of-specification potency results at the 30-day stability timepoint.
AvKARE Inc. is recalling Metformin Hydrochloride Extended-Release Tablets 750 mg because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Hikma Pharmaceuticals is recalling 17,998 vials of Irinotecan Hydrochloride Injection due to a crimp defect in the flip-cap.
Hikma Pharmaceuticals is recalling 82,426 vials of Irinotecan Hydrochloride Injection due to a crimp defect in the flip-cap.
GSK is recalling Gaviscon Regular Strength Liquid Antacid bottles because the labels lack a required magnesium safety warning.
Eco Lips Inc. is recalling 68,400 tubes of EcoLips Sport Lip Balm, SPF 30, because the avobenzone concentration exceeds FDA limits.
GSK is recalling Gaviscon Extra Strength Liquid Antacid because the bottle label is missing a required magnesium safety warning.
Gaviscon Liquid Antacid Extra Strength is being recalled because the bottle label lacks a required magnesium safety warning. The recall covers single and twin-pack bottles distributed nationwide.
Gaviscon Regular Strength Liquid Antacid is being recalled because the bottle label lacks the required magnesium safety warning.
Aurobindo Pharma USA Inc. is recalling Olanzapine Tablets, USP 2.5 mg, because the product failed impurities and degradation specifications.
Aurobindo Pharma USA Inc. is recalling Olanzapine Tablets, USP 7.5 mg, because the product failed impurity and degradation specifications.
Fresenius Kabi is recalling specific lots of Ketorolac Tromethamine Injection because particulate matter was found in reserve sample vials.